bloodwork
Home
Biomarkers
Categories
Panels
Conditions
Reference
LOINC parts
72,372 parts · page 1431 of 1,448 ·
all codes
Part
Name
Type
Tests
LP97055-5
Type of client
COMPONENT
1
LP97056-3
Type of encounter
COMPONENT
3
LP97057-1
Hours designated
COMPONENT
1
LP97058-9
Care capacity
COMPONENT
1
LP97059-7
Care provided
COMPONENT
1
LP97060-5
Volume of nursing delivery unit or service panel
COMPONENT
1
LP97061-3
Method of care delivery
COMPONENT
1
LP97103-3
Newborn Screening Report summary panel
COMPONENT
1
LP97104-1
Full newborn screening summary report for display or printing
COMPONENT
1
LP97105-8
Newborn screening report - overall interpretation
COMPONENT
1
LP97106-6
Newborn conditions with positive markers
COMPONENT
1
LP97107-4
CYP2C19 gene
COMPONENT
LP97117-3
Referral note
COMPONENT
91
LP97118-1
Cardiovascular disease
METHOD
44
LP97119-9
Geriatric medicine
METHOD
37
LP97120-7
Hematology+Medical oncology
METHOD
27
LP97123-1
Orthopedic surgery
METHOD
2
LP97124-9
Otolaryngology
METHOD
26
LP97125-6
Pulmonary disease
METHOD
25
LP97126-4
Critical care medicine
METHOD
21
LP97127-2
Obstetrics and Gynecology
METHOD
30
LP97129-8
Lupus anticoagulant neutralization.high phospholipid
DIVISORS
LP97133-0
OASIS-C
METHOD
41
LP97134-8
Date of Physician-ordered Start of Care (Resumption of Care)
COMPONENT
1
LP97135-5
Risk factors affecting health status and or outcome
COMPONENT
1
LP97139-7
Reason pneumococcal vaccine not given
COMPONENT
1
LP97140-5
Patient lives alone
COMPONENT
1
LP97141-3
Patient lives with other person
COMPONENT
1
LP97142-1
Patient lives in congregated situtation
COMPONENT
1
LP97150-4
Pressure ulcer assessment
COMPONENT
LP97152-0
Number of pressure ulcers - unstageable due to non-removable dressing or device
COMPONENT
1
LP97156-1
Pressure ulcer width
COMPONENT
1
LP97159-5
Current number of stage 1 pressure ulcers
COMPONENT
1
LP97165-2
Symptoms in heart failure patients
COMPONENT
1
LP97170-2
Self-care
COMPONENT
1
LP97172-8
Transfer
COMPONENT
1
LP97173-6
Medication intervention
COMPONENT
LP97174-4
Patient/caregiver received high risk drug education
COMPONENT
1
LP97180-1
Supervision and safety
COMPONENT
LP97181-9
Advocacy or facilitation of patient participation
COMPONENT
LP97182-7
ADL or IADL assistance frequency from any caregiver
COMPONENT
1
LP97183-5
Patient-specific parameters for notifying physician of changes
COMPONENT
LP97186-8
Medication follow-up
COMPONENT
2
LP97187-6
Patient/caregiver drug education intervention
COMPONENT
2
LP97188-4
Date of Referral
COMPONENT
1
LP97189-2
Episode Timing
COMPONENT
1
LP97194-2
Formal pain assessment using standardized tool
COMPONENT
1
LP97195-9
Heart failure follow-up
COMPONENT
1
LP97196-7
Depression screening
COMPONENT
LP97197-5
Household tasks
COMPONENT
1
← prev
·
next →